AI Verdict
CME has stronger fundamentals based on our AI analysis.
CME vs MS Fundamental Comparison
| Metric | CME | MS |
|---|---|---|
| Revenue | $6.5B | $59.1B |
| Net Income | $4.1B | $16.9B |
| Net Margin | 62.5% | 28.5% |
| ROE | 14.2% | 15.1% |
| ROA | 2.1% | 1.2% |
| Current Ratio | 1.03x | N/A |
| Debt/Equity | 0.00x | 3.06x |
| EPS | $11.16 | $10.21 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CME vs MS: Frequently Asked Questions
Is CME or MS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), CME has stronger fundamentals. CME is rated BUY (86% confidence) while MS is rated HOLD (70% confidence). This is not investment advice.
How does CME compare to MS fundamentally?
CME GROUP INC. has ROE of 14.2% vs MORGAN STANLEY's 15.1%. Net margins are 62.5% vs 28.5% respectively.
Which stock pays higher dividends, CME or MS?
CME has a dividend yield of N/A or no dividend while MS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CME or MS for long term?
For long-term investing, consider that CME has BUY rating with 86% confidence, while MS has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CME vs MS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CME vs MS, the AI consensus favors CME based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.